Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Paoletti

Showing results (41-50 of 300) with videos related to

Pageof 30
Sort By:
Minerva Medica|April 14, 1973
[Hypolipemic agents]R Paoletti, R Fumagalli, R Sirtori
Journal of Psychiatric Research|January 1, 1974
A mass fragmentographic study of amphetamine and metabolites in rat brainF Cattabeni, G Racagni, R Paoletti
Biochimica Et Biophysica Acta|November 18, 1974
The (n-6)pentaene:(n-3)hexane fatty acid ratio as an index of linolenic acid deficiencyC Galli, E Agradi, R Paoletti
Handbook of Experimental Pharmacology|April 7, 2006
Lipid and non-lipid effects of statinsR Paoletti, C Bolego, A Cignarella
Journal of Cardiovascular Pharmacology|January 1, 1985
Pathological significance of the thromboxane-prostacyclin hypothesisR Paoletti, P Maderna, E Tremoli
Advances in Prostaglandin and Thromboxane Research|January 1, 1976
Prostaglandin-releasing polymersP Ferruti, R Paoletti, L Puglisi
Thrombosis Research. Supplement|January 1, 1990
Mode of action of PGI2 and of its stable derivative iloprost on platelets and leukocytesE Tremoli, S Colli, R Paoletti
Advances in Experimental Medicine and Biology|January 1, 1984
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studiesE Tremoli, S Colli, R Paoletti
Cardiovascular Drugs and Therapy|November 21, 2001
Safety of HMG-CoA reductase inhibitors: focus on atorvastatinF Bernini, A Poli, R Paoletti
Experientia|October 15, 1971
Antagonism of dibutyryl-Guo-3':5'-P and atropine on stomach smooth muscle contractionL Puglisi, F Berti, R Paoletti
Pageof 30

Showing results (41-50 of 300) with videos related to

Sort By:
Pageof 30
Minerva Medica|April 14, 1973
[Hypolipemic agents]R Paoletti, R Fumagalli, R Sirtori
Journal of Psychiatric Research|January 1, 1974
A mass fragmentographic study of amphetamine and metabolites in rat brainF Cattabeni, G Racagni, R Paoletti
Biochimica Et Biophysica Acta|November 18, 1974
The (n-6)pentaene:(n-3)hexane fatty acid ratio as an index of linolenic acid deficiencyC Galli, E Agradi, R Paoletti
Handbook of Experimental Pharmacology|April 7, 2006
Lipid and non-lipid effects of statinsR Paoletti, C Bolego, A Cignarella
Journal of Cardiovascular Pharmacology|January 1, 1985
Pathological significance of the thromboxane-prostacyclin hypothesisR Paoletti, P Maderna, E Tremoli
Advances in Prostaglandin and Thromboxane Research|January 1, 1976
Prostaglandin-releasing polymersP Ferruti, R Paoletti, L Puglisi
Thrombosis Research. Supplement|January 1, 1990
Mode of action of PGI2 and of its stable derivative iloprost on platelets and leukocytesE Tremoli, S Colli, R Paoletti
Advances in Experimental Medicine and Biology|January 1, 1984
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studiesE Tremoli, S Colli, R Paoletti
Cardiovascular Drugs and Therapy|November 21, 2001
Safety of HMG-CoA reductase inhibitors: focus on atorvastatinF Bernini, A Poli, R Paoletti
Experientia|October 15, 1971
Antagonism of dibutyryl-Guo-3':5'-P and atropine on stomach smooth muscle contractionL Puglisi, F Berti, R Paoletti
Pageof 30